---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-079918"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2023-09-27T23:59:59+00:00"
generated_at: "2026-06-10T08:21:31.038749+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Allarity reduces Series A preferred conversion price to $1.00, cuts warrant exercise price

## Summary
- Conversion price of Series A Preferred Stock amended from $4.50 to $1.00 per share.
- Exercise price of existing warrants reduced to $1.00, matching the September 14 closing price.
- New inducement warrants issued at $1.00 exercise price upon exercise of existing warrants.
- Waiver from 3i, LP permits resale registration for shares underlying inducement warrants.

## SEC filing metadata
- accession: 0001213900-23-079918
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2023-09-27T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390023079918/0001213900-23-079918-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390023079918/ea185840-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-079918
- JSON: https://secwatch.observer/filing/0001213900-23-079918.json
- Plain text: https://secwatch.observer/filing/0001213900-23-079918.txt

## Key facts
- Governance Changes
  Allarity Therapeutics, Inc.: Fourth Certificate of Amendment to Amended and Restated Certificate of Designations of Series A Convertible Preferred Stock filed to reduce the conversion price from $4.50 to $1.00 (effective 2023-09-22).
  - Change: charter amendment
  - Effective: 2023-09-22
  source text: On September 22, 2023 the Company filed the Fourth Certificate of Amendment to Amended and Restated Certificate of Designations of Series A Convertible Preferred Stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390023079918/0001213900-23-079918-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.